115 related articles for article (PubMed ID: 36778224)
1. SCCA1/SERPINB3 promotes suppressive immune environment via STAT-dependent chemokine production, blunting the therapy-induced T cell responses.
Chen L; Shi V; Wang S; Freeman R; Ruiz F; Jayachandran K; Zhang J; Cosper P; Sun L; Luke CJ; Spina C; Grigsby PW; Schwarz JK; Markovina S
bioRxiv; 2023 Feb; ():. PubMed ID: 36778224
[TBL] [Abstract][Full Text] [Related]
2. SCCA1/SERPINB3 suppresses antitumor immunity and blunts therapy-induced T cell responses via STAT-dependent chemokine production.
Chen L; Shi V; Wang S; Sun L; Freeman R; Yang J; Inkman MJ; Ghosh S; Ruiz F; Jayachandran K; Huang Y; Luo J; Zhang J; Cosper P; Luke CJ; Spina CS; Grigsby PW; Schwarz JK; Markovina S
J Clin Invest; 2023 Aug; 133(15):. PubMed ID: 37279067
[TBL] [Abstract][Full Text] [Related]
3. Role of SERPINB3 in hepatocellular carcinoma.
Pontisso P
Ann Hepatol; 2014; 13(6):722-7. PubMed ID: 25332258
[TBL] [Abstract][Full Text] [Related]
4. Serum squamous cell carcinoma antigen as an early indicator of response during therapy of cervical cancer.
Markovina S; Wang S; Henke LE; Luke CJ; Pak SC; DeWees T; Pfeifer JD; Schwarz JK; Liu W; Chen S; Mutch D; Wang X; Powell MA; Siegel BA; Dehdashti F; Silverman GA; Grigsby PW
Br J Cancer; 2018 Jan; 118(1):72-78. PubMed ID: 29112685
[TBL] [Abstract][Full Text] [Related]
5. SERPINB3 (SCCA1) inhibits cathepsin L and lysoptosis, protecting cervical cancer cells from chemoradiation.
Wang S; Luke CJ; Pak SC; Shi V; Chen L; Moore J; Andress AP; Jayachandran K; Zhang J; Huang Y; Platik M; Apicelli AA; Schwarz JK; Grigsby PW; Silverman GA; Markovina S
Commun Biol; 2022 Jan; 5(1):46. PubMed ID: 35022555
[TBL] [Abstract][Full Text] [Related]
6. SERPINB3 in the chicken model of ovarian cancer: a prognostic factor for platinum resistance and survival in patients with epithelial ovarian cancer.
Lim W; Kim HS; Jeong W; Ahn SE; Kim J; Kim YB; Kim MA; Kim MK; Chung HH; Song YS; Bazer FW; Han JY; Song G
PLoS One; 2012; 7(11):e49869. PubMed ID: 23185467
[TBL] [Abstract][Full Text] [Related]
7. Increased myeloid-derived suppressor cells in gastric cancer correlate with cancer stage and plasma S100A8/A9 proinflammatory proteins.
Wang L; Chang EW; Wong SC; Ong SM; Chong DQ; Ling KL
J Immunol; 2013 Jan; 190(2):794-804. PubMed ID: 23248262
[TBL] [Abstract][Full Text] [Related]
8. JAK1/2 inhibitor ruxolitinib promotes the expansion and suppressive action of polymorphonuclear myeloid-derived suppressor cells via the JAK/STAT and ROS-MAPK/NF-κB signalling pathways in acute graft-versus-host disease.
Cao Y; Wang J; Jiang S; Lyu M; Zhao F; Liu J; Wang M; Pei X; Zhai W; Feng X; Feng S; Han M; Xu Y; Jiang E
Clin Transl Immunology; 2023; 12(2):e1441. PubMed ID: 36855558
[TBL] [Abstract][Full Text] [Related]
9. PMN-MDSCs accumulation induced by CXCL1 promotes CD8
Zhou X; Fang D; Liu H; Ou X; Zhang C; Zhao Z; Zhao S; Peng J; Cai S; He Y; Xu J
Cancer Lett; 2022 Apr; 532():215598. PubMed ID: 35176418
[TBL] [Abstract][Full Text] [Related]
10. IgM-linked SerpinB3 and SerpinB4 in sera of patients with chronic liver disease.
Biasiolo A; Tono N; Ruvoletto M; Quarta S; Turato C; Villano G; Beneduce L; Fassina G; Merkel C; Gatta A; Pontisso P
PLoS One; 2012; 7(7):e40658. PubMed ID: 22808225
[TBL] [Abstract][Full Text] [Related]
11. MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy.
Finke J; Ko J; Rini B; Rayman P; Ireland J; Cohen P
Int Immunopharmacol; 2011 Jul; 11(7):856-61. PubMed ID: 21315783
[TBL] [Abstract][Full Text] [Related]
12. SCCA1/SERPINB3 promotes oncogenesis and epithelial-mesenchymal transition via the unfolded protein response and IL6 signaling.
Sheshadri N; Catanzaro JM; Bott AJ; Sun Y; Ullman E; Chen EI; Pan JA; Wu S; Crawford HC; Zhang J; Zong WX
Cancer Res; 2014 Nov; 74(21):6318-29. PubMed ID: 25213322
[TBL] [Abstract][Full Text] [Related]
13. SerpinB3 Upregulates Low-Density Lipoprotein Receptor-Related Protein (LRP) Family Members, Leading to Wnt Signaling Activation and Increased Cell Survival and Invasiveness.
Quarta S; Cappon A; Turato C; Ruvoletto M; Cannito S; Villano G; Biasiolo A; Maggi M; Protopapa F; Bertazza L; Fasolato S; Parola M; Pontisso P
Biology (Basel); 2023 May; 12(6):. PubMed ID: 37372056
[TBL] [Abstract][Full Text] [Related]
14. Increased antiprotease activity of the SERPINB3 polymorphic variant SCCA-PD.
Turato C; Biasiolo A; Pengo P; Frecer V; Quarta S; Fasolato S; Ruvoletto M; Beneduce L; Zuin J; Fassina G; Gatta A; Pontisso P
Exp Biol Med (Maywood); 2011 Mar; 236(3):281-90. PubMed ID: 21383048
[TBL] [Abstract][Full Text] [Related]
15. Squamous Cell Carcinoma Antigen-encoding Genes
Saidak Z; Morisse MC; Chatelain D; Sauzay C; Houessinon A; Guilain N; Soyez M; Chauffert B; Dakpé S; Galmiche A
Anticancer Res; 2018 Mar; 38(3):1343-1352. PubMed ID: 29491058
[TBL] [Abstract][Full Text] [Related]
16. Elevated levels of polymorphonuclear myeloid-derived suppressor cells in patients with glioblastoma highly express S100A8/9 and arginase and suppress T cell function.
Gielen PR; Schulte BM; Kers-Rebel ED; Verrijp K; Bossman SA; Ter Laan M; Wesseling P; Adema GJ
Neuro Oncol; 2016 Sep; 18(9):1253-64. PubMed ID: 27006175
[TBL] [Abstract][Full Text] [Related]
17. SerpinB3 drives cancer stem cell survival in glioblastoma.
Lauko A; Volovetz J; Turaga SM; Bayik D; Silver DJ; Mitchell K; Mulkearns-Hubert EE; Watson DC; Desai K; Midha M; Hao J; McCortney K; Steffens A; Naik U; Ahluwalia MS; Bao S; Horbinski C; Yu JS; Lathia JD
Cell Rep; 2022 Sep; 40(11):111348. PubMed ID: 36103817
[TBL] [Abstract][Full Text] [Related]
18. Squamous cell carcinoma antigen 1 and 2 expression in cultured normal peripheral blood mononuclear cells and in vulvar squamous cell carcinoma.
Chechlinska M; Kowalewska M; Brzoska-Wojtowicz E; Radziszewski J; Ptaszynski K; Rys J; Kaminska J; Nowak R
Tumour Biol; 2010 Dec; 31(6):559-67. PubMed ID: 20589490
[TBL] [Abstract][Full Text] [Related]
19. Study on the targeted therapy of oral squamous cell carcinoma with a plasmid expressing PE38KDEL toxin under control of the SERPINB3 promoter.
Wu J; Guo Q; Zhang G; Zhao L; Lv Y; Wang J; Liu J; Shi W
Cancer Med; 2020 Mar; 9(6):2213-2222. PubMed ID: 32017381
[TBL] [Abstract][Full Text] [Related]
20. Aiduqing formula inhibits breast cancer metastasis by suppressing TAM/CXCL1-induced Treg differentiation and infiltration.
Li J; Wang S; Wang N; Zheng Y; Yang B; Wang X; Zhang J; Pan B; Wang Z
Cell Commun Signal; 2021 Aug; 19(1):89. PubMed ID: 34461944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
